<?xml version="1.0" encoding="UTF-8"?>
<p>Experiments by Lu and colleagues demonstrated that the Fragment antigen-binding, F(abâ€™) 2 region of an equine anti-H5N1 antibody could protect mice against a lethal challenge of influenza H5N1 [
 <xref rid="B133-vaccines-07-00053" ref-type="bibr">133</xref>]. Such an example shows that use of passive immunotherapy during influenza outbreaks could complement the use of available antivirals that would increase the survival in both humans and other animals. 
</p>
